{"id":"https://openalex.org/W4403437074","doi":"https://doi.org/10.1158/1078-0432.27231372","title":"Supplementary Figure S3 from Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients","display_name":"Supplementary Figure S3 from Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients","publication_year":2024,"publication_date":"2024-10-15","ids":{"openalex":"https://openalex.org/W4403437074","doi":"https://doi.org/10.1158/1078-0432.27231372"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.27231372","doi":"https://doi.org/10.1158/1078-0432.27231372","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.27231372","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.27231372","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093396323","display_name":"Tobias Tix","orcid":"https://orcid.org/0009-0003-9279-0491","observed_orcids":["https://orcid.org/0009-0003-9279-0491"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tobias Tix","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-9279-0491","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076270634","display_name":"Mohammad Alhomoud","orcid":"https://orcid.org/0000-0003-4552-0109","observed_orcids":["https://orcid.org/0000-0003-4552-0109"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad Alhomoud","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4552-0109","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033851673","display_name":"Roni Shouval","orcid":"https://orcid.org/0000-0001-9827-8032","observed_orcids":["https://orcid.org/0000-0001-9827-8032"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roni Shouval","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9827-8032","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088177143","display_name":"Edward R. Scheffer Cliff","orcid":"https://orcid.org/0000-0001-5977-907X","observed_orcids":["https://orcid.org/0000-0001-5977-907X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward R. Scheffer Cliff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5977-907X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082333371","display_name":"Miguel\u2010Angel Perales","orcid":"https://orcid.org/0000-0002-5910-4571","observed_orcids":["https://orcid.org/0000-0002-5910-4571"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miguel-Angel Perales","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5910-4571","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077373109","display_name":"David M. Cordas dos Santos","orcid":"https://orcid.org/0000-0002-9198-8338","observed_orcids":["https://orcid.org/0000-0002-9198-8338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Cordas dos Santos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9198-8338","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054210888","display_name":"Kai Rejeski","orcid":"https://orcid.org/0000-0003-3905-0251","observed_orcids":["https://orcid.org/0000-0003-3905-0251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Rejeski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3905-0251","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.031099999323487282,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/second-primary-malignancy","display_name":"second primary malignancy","score":0.9300000071525574},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7179999947547913},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.7450000047683716},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6487847566604614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.639541745185852},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5938323736190796},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5789478421211243},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5445374250411987},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5379908680915833}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.27231372","doi":"https://doi.org/10.1158/1078-0432.27231372","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.27231372","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/27231372","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S3_from_Second_Primary_Malignancies_after_CAR_T-Cell_Therapy_A_Systematic_Review_and_Meta-analysis_of_5_517_Lymphoma_and_Myeloma_Patients/27231372","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.27231372","doi":"https://doi.org/10.1158/1078-0432.27231372","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.27231372","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402452346","https://openalex.org/W4403436798","https://openalex.org/W4415898853","https://openalex.org/W7123363828","https://openalex.org/W7162681018","https://openalex.org/W4414303905","https://openalex.org/W4410809892","https://openalex.org/W4405051509","https://openalex.org/W4410795624","https://openalex.org/W4417002400"],"abstract_inverted_index":{"Subgroup":[0],"analysis":[1],"of":[2],"SPM":[3],"point":[4],"estimates":[5],"stratified":[6],"by":[7],"CAR":[8],"T-cell":[9],"products.":[10]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2024-10-16T00:00:00"}